MUC16 and female reproductive organ cancer: We demonstrate direct semi‐quantitative detection of a panel of biomarkers that are often associated with infection and inflammation (C‐reactive protein), gynecological cancers (CEA and CA‐125) and gynecological disorders such as endometriosis (CA‐125) in menstrual blood.